One of the most common concerns parents have when researching treatment for short stature is whether growth hormone therapy could increase a child's cancer risk. After reading online forums, social media discussions, and conflicting health information, many families ask the same question:
Can HGH cause cancer in children?
The short answer is that current medical evidence does not show an increased risk of cancer in otherwise healthy children receiving properly prescribed and monitored human growth hormone (HGH) therapy.
However, the answer is more nuanced than a simple yes or no.
Growth hormone affects growth and cellular activity throughout the body. Because cancer also involves abnormal cell growth, many parents naturally wonder whether growth hormone treatment could somehow trigger tumors or increase the risk of cancer later in life.
Fortunately, decades of pediatric research, long-term safety monitoring, and extensive clinical experience have provided reassuring answers. Understanding what HGH does, how it works, and what the scientific evidence actually shows can help parents make informed decisions about treatment.
Quick Answer: Does HGH Cause Cancer in Children?
For children without active cancer or certain rare genetic conditions, studies have not shown that medically supervised growth hormone therapy causes cancer.
Major pediatric endocrine organizations continue to recommend HGH treatment for appropriate medical conditions, including:
- Growth Hormone Deficiency
- Idiopathic Short Stature
- Poor Growth Velocity
- Children born small for gestational age
- Turner syndrome
- Certain genetic growth disorders
Doctors still perform careful screening before treatment begins, but current evidence does not support the belief that HGH creates cancer in healthy children.
Why Does This Myth Exist?
Much of the concern comes from misunderstanding how growth hormone functions within the body.
Growth hormone naturally stimulates:
- Bone growth
- Muscle development
- Organ maturation
- Tissue repair
- Production of IGF-1
Because growth hormone promotes normal growth, many people assume it could also stimulate cancer growth.
While this may sound logical on the surface, it oversimplifies a very complex biological process.
Normal Growth Is Not the Same as Cancer Growth
Healthy growth occurs through tightly regulated signaling pathways.
Normal growth involves:
- Controlled cell division
- Hormonal regulation
- Genetic oversight
- Proper tissue development
Cancer is fundamentally different.
Cancer develops when genetic mutations cause cells to grow uncontrollably and ignore the body's normal regulatory systems.
Growth hormone supports normal growth processes. It does not create the genetic mutations responsible for cancer development.
This distinction is one of the most important facts parents should understand.
Understanding What HGH Actually Does
Human growth hormone is not a foreign chemical.
It is a hormone naturally produced by the pituitary gland located at the base of the brain.
Throughout childhood, growth hormone helps regulate:
- Height growth
- Bone development
- Muscle formation
- Metabolism
- Energy production
Children diagnosed with Growth Hormone Deficiency often produce insufficient amounts of this hormone, leading to slower growth and delayed physical development.
Treatment aims to restore normal physiologic hormone levels—not create excessive growth.
Likewise, children with Low IGF-1 may have impaired growth signaling even when growth hormone production appears normal.
The purpose of treatment is to support healthy development, not push the body beyond its natural limits.
What Do Long-Term Studies Show?
One reason pediatric endocrinologists feel confident discussing HGH safety is because growth hormone therapy has been used for decades.
Researchers have followed thousands of children who received growth hormone treatment and tracked outcomes into adulthood.
These studies consistently show:
- No evidence that HGH causes new cancers in healthy children
- No increased risk of leukemia in otherwise healthy patients
- No evidence HGH initiates tumors
- No increase in overall childhood cancer incidence
Several large international registries continue to monitor patients who received growth hormone therapy during childhood.
Overall findings remain reassuring when treatment is appropriately prescribed and monitored.
Why Doctors Screen Before Starting HGH Therapy
Some parents hear that cancer screening is performed before treatment and assume this means HGH causes cancer.
In reality, screening is simply part of responsible medical care.
Before starting treatment, providers evaluate:
- Medical history
- Family history
- Previous cancers
- Neurologic symptoms
- Growth patterns
- Laboratory testing
- Imaging when indicated
The goal is to identify any underlying condition that could affect treatment decisions.
This careful evaluation is one reason growth hormone therapy maintains an excellent safety profile.
If your child has concerns about short stature or slow growth, a comprehensive pediatric growth evaluation helps determine whether treatment may be appropriate.
Situations Where Extra Caution Is Needed
Although growth hormone therapy is considered safe for most children, there are circumstances where additional precautions are necessary.
Children With a History of Cancer
Some childhood cancer survivors develop growth hormone deficiency after chemotherapy or radiation therapy.
In these situations, treatment decisions are individualized and often involve collaboration between:
- Pediatric endocrinologists
- Pediatric oncologists
- Primary care physicians
Many childhood cancer survivors successfully receive HGH therapy after appropriate evaluation.
Active Malignancy
Growth hormone therapy is generally not initiated in children with active cancer.
Treatment focuses first on controlling the malignancy.
Genetic Cancer Syndromes
Rare inherited conditions associated with increased cancer risk may require specialized evaluation.
Examples include:
- Li-Fraumeni syndrome
- Neurofibromatosis
- Multiple endocrine neoplasia syndromes
Treatment decisions in these cases are highly individualized.
Certain Pituitary Disorders
Children diagnosed with Pituitary Disorders may require additional imaging studies before treatment begins.
A pituitary MRI can help identify structural abnormalities and guide treatment planning.
What About IGF-1 and Cancer Risk?
Another source of confusion involves IGF-1.
Growth hormone stimulates the liver to produce Insulin-Like Growth Factor-1 (IGF-1), which plays a major role in childhood growth.
Because IGF-1 promotes cell growth, some people assume higher IGF-1 automatically means higher cancer risk.
The reality is more complicated.
IGF-1 is essential for:
- Bone growth
- Muscle development
- Normal puberty
- Childhood development
Children with Low IGF-1 often experience significant growth challenges.
During therapy, doctors routinely monitor IGF-1 levels to ensure they remain within a healthy age-appropriate range.
The goal is physiologic replacement—not excessive hormone exposure.
Can HGH Cause Leukemia?
This is one of the most frequently searched questions online.
Years ago, isolated reports raised concerns about leukemia risk among children receiving growth hormone.
Subsequent research found that many of those patients had underlying medical conditions that independently increased cancer risk.
Modern research has shown:
- No increased leukemia risk in healthy children
- No evidence HGH causes blood cancers
- No evidence HGH initiates leukemia development
Current pediatric endocrine guidelines continue to support HGH therapy when medically indicated.
Why Monitoring Matters During Treatment
Even though cancer risk is not increased in healthy children, regular follow-up remains essential.
Monitoring helps physicians:
- Assess growth response
- Review side effects
- Adjust dosage
- Monitor IGF-1 levels
- Evaluate overall development
Routine follow-up appointments often include:
- Height measurements
- Weight tracking
- Growth velocity calculations
- Bone age assessments
- Laboratory testing
This ongoing monitoring helps ensure treatment remains both safe and effective.
Risks That Are More Relevant Than Cancer
Ironically, the side effects parents spend the most time worrying about are not usually the ones physicians monitor most closely.
Potential treatment-related concerns include:
Headaches
Persistent headaches should always be reported to a provider.
Joint Pain
Temporary aches occasionally occur during periods of rapid growth.
Fluid Retention
Some children experience mild swelling early in treatment.
Blood Sugar Changes
Rare metabolic changes can occur and are monitored during follow-up.
Growth Plate Complications
Although uncommon, certain orthopedic issues can develop during periods of accelerated growth.
These side effects are generally rare and manageable when recognized early.
Could Not Treating a Growth Disorder Be the Greater Risk?
An important perspective often missing from online discussions is the potential impact of untreated growth disorders.
Children with untreated Growth Hormone Deficiency may experience:
- Significantly reduced adult height
- Delayed physical development
- Reduced bone density
- Delayed puberty
- Emotional distress related to short stature
Likewise, children with Poor Growth Velocity, Delayed Bone Age, or Idiopathic Short Stature may benefit from early evaluation to identify underlying causes.
The decision to pursue treatment should consider both potential benefits and risks—not just fears surrounding growth hormone therapy.
Frequently Asked Questions
Can HGH cause cancer in healthy children?
Current evidence shows no increased cancer risk in otherwise healthy children receiving medically supervised HGH therapy.
Does growth hormone cause leukemia?
Modern studies have not found an increased leukemia risk among healthy children treated with HGH.
Why do doctors monitor IGF-1 levels?
Monitoring helps ensure hormone levels remain within a normal physiologic range and supports safe treatment.
Can childhood cancer survivors receive HGH?
In many cases, yes. Treatment decisions are individualized and coordinated with oncology specialists.
Is HGH approved for children?
Yes. HGH is FDA-approved for several pediatric conditions involving impaired growth and short stature.
How do I know if my child needs testing?
Children with slow growth, short stature, or abnormal growth patterns may benefit from evaluation. Articles such as Signs Your Child May Need Growth Hormone Testing can help parents understand when further assessment is appropriate.
The Bottom Line
So, can HGH cause cancer in children?
Based on decades of pediatric research, long-term follow-up studies, and current medical guidelines, there is no evidence that properly prescribed growth hormone therapy causes cancer in otherwise healthy children.
The myth largely stems from confusion about how growth hormone works.
Growth hormone supports normal childhood development. Cancer develops through abnormal genetic changes and uncontrolled cellular growth—two very different biological processes.
For children with diagnosed growth disorders, early evaluation, careful screening, and ongoing monitoring allow physicians to safely support healthy growth while maintaining a strong focus on long-term safety.
If your child is experiencing slow growth, short stature, delayed development, or concerns about hormone levels, a comprehensive growth evaluation can help determine the underlying cause and identify appropriate treatment options.
Medically Reviewed By
Dr. Devin Stone, ND
Dr. Devin Stone is a Doctor of Naturopathic Medicine and founder of HGHforChildren.com. His clinical focus includes pediatric growth optimization, growth hormone deficiency, delayed bone age assessment, constitutional growth delay, IGF-1 evaluation, and evidence-informed therapies designed to help children maximize healthy growth potential.
References
- Pediatric Endocrine Society. Growth Hormone Deficiency Guidelines.
- Endocrine Society Clinical Practice Guidelines.
- Growth Hormone Research Society Consensus Statements.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- National Institutes of Health (NIH).
- Hormone Research in Paediatrics.
- American Academy of Pediatrics.
- Safety of Recombinant Human Growth Hormone in Childhood Studies.
Dr. Devin Stone
Contact Me
